Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Biochem Pharmacol. 2012 Jul 22;84(7):936–948. doi: 10.1016/j.bcp.2012.07.010

Table 4.

Affinities of hGRPR point mutants in Group IV for [D-Tyr6, β-Ala11, Phe13, Nle14]Bn(6-14) [Univ.Lig]

LOCATION POINT MUTATION Univ.Lig Affinity (nM ± SEM)
Wild type hGRPR 0.1×106 - 0.10 ± 0.01
4 EC2 D97N 1.24 ± 0.01*
80 D97A 1.13 ± 0.06*
81 D97E 0.19 ± 0.02*
10 D104K 0.20 ± 0.01*
82 D104A 0.20 ± 0.01*
83 D104N 0.30 ± 0.02*
14 G112V 2.98 ± 0.15*
84 G112A 0.15 ± 0.01*
16 UTM3 I116A 0.18 ± 0.01*
85 I116K 0.22 ± 0.01*
86 I116L 0.055 ± 0.010
87 I116M 0.051 ± 0.004
18 L121A 0.48 ± 0.02*
88 L121I 0.067 ± 0.012
89 L121K 0.29 ± 0.01*
90 L121M 0.13 ± 0.01
70 EC3 I209W 0.27 ± 0.01*
91 I209A 0.27 ± 0.01*
33 I283A 0.47 ± 0.02*
92 UTM6 I283K 1.75 ± 0.11*
93 I283L 0.22 ± 0.01
94 I283M 0.36 ± 0.01
34 Y284A 5.78 ± 0.33*
95 Y284F 0.16 ± 0.01*
96 Y284L 2.53 ± 0.14*
97 Y284W 4.22 ± 0.26*
35 R287N 7.07 ± 0.47*
98 R287K 1.02 ± 0.05*
75 EC4 D295S 0.18 ± 0.02*
99 D295A 0.46 ± 0.01*
38 H300S 0.99 ± 0.03*
100 H300A 0.15 ± 0.01*
78 V302I 0.35 ± 0.01*
101 V302A 0.060 ± 0.001

Group IV (22 new mutations) include hGRPR point mutants made to explore the important properties of the amino acid replacement made in that position that was found to alter the affinity for [D-Tyr6, β-Ala11, Phe13, Nle14]Bn(6-14) [Univ.Lig] and identified in Tables 13. Experiments were performed as described in Table 1, and Fig. 1, 3 and 4 Figure legends. The affinities (IC50) were calculated as described in Methods. Each point mutation’s affinity for Univ.Lig was compared to that of cells expressing wild type GRPR. Values are means ± SEM from three experiments for those mutants showing no affinity change and 4 to 6 experiments for any showing differences from control and in each experiment each point was measured in duplicate.

*

(in bold)=p<0.05 compared to wild type hGRPR expressed at similar expression levels.